This case simulation—grounded in patterns observed across hundreds of clinical consultations—is designed to support evidence-informed interpretation of the Hormone Zoomer (Female) Sample Report.
A 39-year-old female (BMI 23.5) presenting with chronic fatigue, weight gain, irregular menstrual cycles with premenstrual spotting, mood swings, insomnia, and joint pain.
She works in a high-stress corporate role as a project manager and reports difficulty falling asleep due to racing thoughts, though she sleeps deeply once asleep. Her lifestyle includes regular weightlifting and a generally healthy diet, but also frequent use of conventional personal care products, plastic water bottles, black plastic cookware, plastic food storage containers, and a plastic dental night guard worn nightly.
Her history is notable for infertility, increasing stress levels, and progressively worsening PMS symptoms. At the time of testing, she also reported current use of DIM and a dietary supplement containing white peony and licorice.
The most striking feature of the patient’s Hormone Zoomer results is the markedly elevated cortisol output across both saliva and urine testing, with an exaggerated cortisol awakening response (CAR) and persistently elevated cortisol production throughout the day.
Elevated waking salivary cortisol and increased pooled urine free cortisol suggest sustained hypothalamic-pituitary-adrenal (HPA) axis activation and a persistent “fight-or-flight” physiology.
This pattern is commonly associated with:
Although saliva cortisone levels remain within range, the elevated urinary cortisol:cortisone ratio may suggest altered cortisol metabolism and reduced peripheral conversion/inactivation of cortisol.
Clinical Implication:
Sustained cortisol exposure has been associated with:
Mood swings
Insomnia
Central weight gain
At the time of testing, the patient had been taking a dietary supplement containing white peony and licorice to support estrogen production.
White peony has been studied for its potential influence on aromatase activity and hormone metabolism, while licorice may inhibit 11β-HSD2, the enzyme responsible for converting active cortisol into inactive cortisone.
In individuals with elevated cortisol patterns, licorice may contribute to prolonged cortisol activity and altered cortisol:cortisone dynamics.
Clinical Considerations:
Licorice-containing protocols should be used cautiously in patients with:
The patient’s Hormone Zoomer results demonstrated a strong preference for 2-hydroxylation within Phase 1 estrogen metabolism.
Findings include:
This pattern is consistent with increased CYP1A1 pathway activity and may reflect the influence of DIM supplementation.
Clinical Considerations:
At first glance, preferential 2-OH metabolism is often viewed favorably due to reduced proliferative signaling compared with the 16-OH pathway. However, estrogen metabolism must be evaluated in the broader context of downstream detoxification and clearance capacity.
Despite robust Phase 1 estrogen metabolism, the patient’s results suggest incomplete downstream clearance of activated estrogen metabolites.
Key findings include:
This creates a functional bottleneck in which estrogen metabolites are successfully activated during Phase 1 detoxification but are not efficiently neutralized and eliminated during Phase 2 metabolism.
Clinical Implications:
This pattern may contribute to:
Elevated 8-OHdG further supports increased oxidative stress and oxidative DNA damage.
Although several progesterone metabolites remain within reference range, the patient’s results demonstrate altered downstream progesterone metabolism patterns.
Key findings include:
This pattern suggests relatively elevated progesterone metabolite activity compared with estradiol, while also indicating reduced downstream conversion into certain neuroactive progesterone metabolites.
Clinical Implications:
Neuroactive progesterone metabolites play important roles in:
Reduced downstream conversion may contribute to symptoms such as:
This case highlights the importance of evaluating not only absolute hormone levels, but also downstream metabolic pathways and functional hormone signaling.
The patient’s results demonstrated elevated levels of several endocrine disruptors, including:
Combined with her reported exposures:
These findings suggest a meaningful exogenous endocrine disruptor burden.
Clinical Relevance:
BPA exhibits estrogenic activity and may interfere with normal endocrine signaling, while glyphosate exposure has been associated with microbiome disruption, oxidative stress, and impaired detoxification pathways.
Bone health markers remained within range, consistent with the patient’s regular resistance training and weightlifting routine.
This represents an important protective factor in the setting of chronic stress and hormonal dysregulation.
The patient’s Hormone Zoomer results demonstrate a complex, multi-system pattern involving:
This case highlights several important clinical principles: